Type to search

Manufacturing News Technology

AstraZeneca appoints Nazneen Rahman to Board of Directors


Professor Nazneen Rahman today joined the Board of Directors and Science Committee at AstraZeneca.

Rahman is head of the Divison of Genetics and Epidemiology at the Institute of Cancer Research in London. She is also the head of the cancer genetics unit at the Royal Marsden NHS Foundation.

Her research combines clinical and scientific knowledge to create new treatments for human disease genes, in particular, cancer predisposition genes.

“We are delighted to welcome Professor Rahman to our Board and Science Committee. She brings world-renowned expertise in genetic research with a focus on cancer, which is a strategic therapy area for our business,” said Leif Johansson, chairman of AstraZeneca.

Get the free DBT email newsletter  

Follow the people, companies and issues that matter most to business in Delaware.


You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Limited time offer. New subscribers only.

Flash Sale! Subscribe to Delaware Business Times and save 50%.

Limited time offer. New subscribers only.